CNSL — Cambridge Nutritional Sciences Income Statement
0.000.00%
Last trade - 00:00
- £9.40m
- £5.22m
- £7.55m
- 25
- 40
- 91
- 51
2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.76 | 9.82 | 6.82 | 8.54 | 7.55 |
Cost of Revenue | |||||
Gross Profit | 5.63 | 6.29 | 4 | 5.1 | 3.54 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.03 | 17.9 | 7.28 | 9.47 | 10.8 |
Operating Profit | -0.271 | -8.05 | -0.468 | -0.929 | -3.24 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.368 | -8.3 | -0.546 | -0.95 | -3.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.34 | -6.83 | 0.385 | -1.41 | -3.17 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.974 | -6.83 | -2.1 | -11.3 | -3.86 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.974 | -6.83 | -2.1 | -11.3 | -3.86 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.002 | 0.016 | 0.002 | 0 | -0.012 |